Beta Bionics CFO Stephen Feider reports sale of 382 common shares worth $6,507.999918
BBNX•Beta Bionics CFO Stephen Feider sold 382 common shares at $17.0366 each and exercised options for 382 shares at $5.10 each on November 5, 2026. After the transactions, he directly held 159,378 common shares and 39,313 employee stock options.
1. Transactions disclosed
Stephen Feider, chief financial officer of Beta Bionics, sold 382 common shares at $17.0366 each on November 5, 2026, and exercised employee stock options for 382 common shares at $5.10 each. Following the transactions, he directly held 159,378 common shares and 39,313 employee stock options.
